PHASE 1 STUDY OF ANTICD19 CAR-T CELLS WITH TNFα TRANSMEMBRANE DOMAIN AND 41BB, CD3ζ COSTIMULATORY DOMAINS. RESPONSES IN SUBJECTS WITH RAPIDLY PROGRESSIVE LYMPHOMA

Hematological Oncology - United Kingdom
doi 10.1002/hon.115_2630
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Expansion Deficiency of CAR-T Cells in Patients With Lymphoma and Resolution by T Cell Purification

British Journal of Haematology
Hematology
2019English

Targeting Glioblastoma With CAR T Cells

Cancer Discovery
Oncology
2017English

Next Generation Car T Cells for Lymphoma and Beyond

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Correction To: Multicenter Phase 1/2 Study of Forodesine in Patients With Relapsed Peripheral T Cell Lymphoma

Annals of Hematology
MedicineHematology
2018English

Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

Armed T Cells With CAR for Cancer Immunotherapy

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2016English

Idiopathic Bilateral Sensorineural Hearing Loss (IBSH): Clinical Study of Cases With Rapidly Progressive and Slowly Progressive Deafness.

AUDIOLOGY JAPAN
2010English

Targeting High-Risk Pediatric Solid Tumors With CAR T Cells Directed Against ALK (Anaplastic Lymphoma Kinase, CD246)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Skewed Representation of Functionally Distinct Populations of Virus-Specific CD4 T Cells in HIV-1-infected Subjects With Progressive Disease: Changes After Antiretroviral Therapy

Blood
BiochemistryImmunologyCell BiologyHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy